Clinical & translational oncology

• 

  Año 2025, Vol. 27, Número 1

  • REVIEW ARTICLE

    • Tumor‑treating fields in cancer therapy: advances of cellular and molecular mechanisms

      Tong Xiao, Hao Zheng, Kaiyang Zu, Youjia Yue, Ying Wang

      • Resumen

      págs. 1-14

      

    • Specific microbiome patterns and their association with breast cancer: the intestinal microbiota as a potential biomarker and therapeutic strategy

      Alba Amaro da Cruz, Teresa Rubio Tomás, Ana Isabel Alvarez Mercado

      • Resumen

      págs. 15-41

      

    • Shifting cold to hot tumors by nanoparticle‑loaded drugs and products

      Irfan Ahmad, Kamil K. Atiyah Altameemi, Mohaned Mohammed Hani, Afaq Mahdi Ali, Hasanain Khaleel Shareef, Zahraa F. Hassan, Mahmood Hasen Shuhata Alubiady, Salah Hassan Zain Al Abdeen, Hussein Ghafel Shakier, Ahmed huseen Redhee

      • Resumen

      págs. 42-69

      

    • The role of AMPK in pancreatic cancer: from carcinogenesis to treatment

      Shahrzad Shahrokhi Nejad, Sepideh Razi, Nima Rezaei

      • Resumen

      págs. 70-82

      

    • Exosomal microRNAs: impact on cancer detection, treatment, and monitoring

      Ram Mohan Ram Kumar

      • Resumen

      págs. 83-94

      

    • Spanish Society of Medical Oncology recommendations for comprehensive assessment and care of cancer survivors’ needs

      Alejandro Gallego Martínez, Carmen Beato Zambrano, Elena Brozos Vázquez, Susana de la Cruz Sánchez, Ruth Vera García

      • Resumen

      págs. 95-107

      

  • SPECIAL ARTICLE

    • Exercise in cancer patients: assistance levels and referral pathways—a position statement from the Spanish Society of Medical Oncology

      Blanca Herrero, Ana Cardeña Gutiérrez, Ana Godoy Ortiz, Ana Gonzaga López, Ana María Grueso López, Ana Nuño Alvés, P. Ramírez Daffós, César Augusto Rodríguez Sánchez, Ángel Rodríguez Pérez, Víctor Sacristán Santos, Salvador Saura Grau, Raquel Sebio, Miguel Ángel Seguí Palmer

      • Resumen

      págs. 108-116

      

  • RESEARCH ARTICLE

    • Prognostic risk stratifcation value of MACC1 expression in patients with gastric cancer

      Xia Zhang, Xing Jun Feng, Qiu Yue Han, Jian Gang Zhang, Wei-hua Yang, Aifen Lin

      • Resumen

      págs. 117-125

      

    • Signifcance of concurrent evaluation of HER2 gene amplifcation and p53 and Ki67 expression in gastric cancer tissues

      Su Nan Wang, Yang kun Wang, Chao Ya Zhu, Bo Jiang, Dong Feng Ge, Ying ying Li

      • Resumen

      págs. 126-134

      

    • A prognostic nomogram to predict the cancer‑specifc survival of patients with initially diagnosed metastatic gastric cancer: a validation study in a Chinese cohort

      Ziming Zhao, Erxun Dai, Bao Jin, Ping Deng, Zulihaer Salehebieke, Bin Han, Rongfan Wu, Zhaowu Yu, Jun Ren

      • Resumen

      págs. 135-150

      

    • Pan‑immune‑infammation value: a new prognostic index in operative laryngeal and pharyngeal carcinomas

      Jiaqi Shi, Chang Liu, Ning Yang, Chen Qiu

      • Resumen

      págs. 151-159

      

    • Predictive capacity for local disease control of neogenin‑1 (NEO1) transcriptional expression in patients with head and neck squamous cell carcinoma

      Xavier León Vintró, Cristina Valero Mayor, Gemma Fuster Orellana, Paloma Bragado Domingo, Mercedes Camacho, Francisco Javier Avilés Jurado

      • Resumen

      págs. 160-165

      

    • The EORTC QLQ43 and FACT H&N questionnaires of quality of life at 1 and 5 years after treatment and dental care in head and neck cancer patients: a pilot study

      Marc Guedea, Meritxell Sánchez Molins, Alicia Lozano, Montse Ferrer, Angels Pont, Ferrán Guedea Edo, Sandra Clotet, Marc Juárez, Pablo Araguas, Montse Ventura, Nuno Oliveira, Josep Mª Ustrell Torrent

      • Resumen

      págs. 166-174

      

    • Immune checkpoint inhibitors‑associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group

      M. Sánchez Cánovas, Miguel Ángel Moya Hernández, Evdochia Adoamnei, Diego Cacho Lavín, David Fernández Garay, Teresa Quintanar, Jacobo Rogado Revuelta, Francisco José García Verdejo, Silvia García Adrián, Ana Isabel Ferrer Pérez, Esperanza Guirao García, Javier López Robles, Jaime Mendiola Olivares, Andrés Jesús Muñoz Martín

      • Resumen

      págs. 175-181

      

    • The efect of narrative nursing on improving the negative emotions and quality of life of patients with moderate to severe cancer pain

      Li-Hua Wu, Jia Li, Shao Fen Jia, Yan Jing Guo

      • Resumen

      págs. 182-188

      

    • Trends in lung cancer incidence in Spain (1990–2019): insights from Global Burden of Diseases data

      Lucía Cayuela Rodríguez, Anna Michela Gaeta, José Luis López-Campos Bodineau, Aurelio Cayuela Domínguez

      • Resumen

      págs. 189-195

      

    • Safety and efcacy of restarting immune checkpoint inhibitors in non‑small cell lung cancer patients following immune‑related adverse events: a systematic review and meta‑analysis

      Kexin Tan, Aolin Wang, Yumin Zheng, Shuo Wang, Chao Wang, Jia Li, Xingyu Lu, Huijing Dong, Jiabin Zheng, Huijuan Cui

      • Resumen

      págs. 196-203

      

    • Comparison of the efcacy and safety of domestically produced tislelizumab, camrelizumab, and imported pembrolizumab in the treatment of advanced NSCLC: a real‑world retrospective study

      Jia Hu, MengTing Li, ZeYu Xie, JiSheng Chen

      • Resumen

      págs. 204-212

      

    • Treatment patterns and humanistic burden of malignant pleural mesothelioma in Spain

      Susana Cedres, Julio Calvete Candenas, Gavin Taylor Stokes, Nestor Alvarez Ayerza, David Vilanova Larena, Melinda Daumont

      • Resumen

      págs. 213-222

      

    • Diferential diagnosis of primary mesenchymal neoplasms of the breast

      Mine Ozsen, Seyit Ali Volkan Polatkan, Ulviye Yalcınkaya, Sahsine Tolunay, Mustafa Sehsuvar Gokgoz

      • Resumen

      págs. 223-232

      

    • Clinical, pathological and gene expression profling of estrogen receptor discordance in breast cancer

      Xi Wang, Shengnan Bao, Mengping Jiang, Xian Zou, Yongmei Yin

      • Resumen

      págs. 233-256

      

    • Cross‑sectional study of hepatitis B virus infection in female breast cancer patients in China for the first time diagnosed

      Zhao‑xing Li, Jie Huang, Lei Hu, Zhi‑yu Jiang, Liang Ran, Xin‑yu Liang, Rui‑ling She, Chen‑yu Ma, Jun‑han Feng, Jing‑yu Song, Xiu‑quan Qu, Bai‑qing Peng, Kai‑nan Wu, Ling‑quan Kong

      • Resumen

      págs. 257-264

      

    • Endoplasmic reticulum stress regulates apoptosis and chemotherapeutic via enhancing TNFRSF10B recycling to the cell membrane in triple‑negative breast cancer

      Dapeng Zhao, Jian Song, Chongyao Ji

      • Resumen

      págs. 265-276

      

    • Serum biomarkers REG1A and REG3A combined with the traditional CEA represent a novel nomogram for the screening and risk stratification of colorectal cancer

      Long Yu, Hao Wang, Fulong Wang, Jian Guo, Binyi Xiao, Zhenlin Hou, Zhenhai Lu, Zhizhong Pan, Yaxian Zhou, Sibin Ye, Desen Wan, Bo Lin, Qingjian Ou, Yujing Fang

      • Resumen

      págs. 277-290

      

    • The effect of combined head and tail approach during laparoscopic D3 lymph node dissection on pain severity and complications in patients with right colon cancer

      Liang Wang, Jun Zhao, Lianghui Shi, Bing Wang, Xiaofeng Zhang

      • Resumen

      págs. 291-298

      

  • REVIEW ARTICLE

    • Enhancing the diagnostic accuracy of colorectal cancer through the integration of serum tumor markers and hematological indicators with machine learning algorithms

      Rongxuan Xu, Huimin Chi, Qian Zhang, Xiaofeng Li, Zhijun Hong

      • Resumen

      págs. 299-308

      

    • Lasso‑Cox interpretable model of AFP‑negative hepatocellular carcinoma

      Han Li, Chengyuan Zhou, Chenjie Wang, Bo Li, Yanqing Song, Bo Yang, Yan Zhang, Xueting Li, Mingyue Rao, Jianwen Zhang, Ke Su, Kun He, Yunwei Han

      • Resumen

      págs. 309-318

      

    • Comprehensive analysis of PSMG3 in pan‑cancer and validation of its role in hepatocellular carcinoma

      Mengli Zheng, Xiaochun Chen, Zhe Xu, Zhitao Ye, Lixian Zhong, Zhicao Chen, Guiquan Chen, Boyong Cai

      • Resumen

      págs. 319-332

      

    • Clinical characteristics and prognosis of pancreatitis associated with immune checkpoint inhibitors

      Junzi Zhang, Xianzhuo Jiang, Ning Liu, Zhaoxue Qi, Xuguang Mi, Yanqiu Fang, Wenqi Zhang, Zhen Yang, Wenjie Ou, Xiuying Lin, Junjie Hou

      • Resumen

      págs. 333-339

      

  • RESEARCH ARTICLE

    • The serum LDH level and KELIM scores are potential predictors of a benefit from bevacizumab first‑line therapy for patients with advanced ovarian cancer

      Yi Liu, Lin Yuan, Zhang Lin, Miao Huixian, Meng Huangyang, Wenjun Cheng

      • Resumen

      págs. 340-350